A Novel Integrated Cognitive-Behavioral Therapy for Anxiety and Medication Adherence Among Persons Living With HIV/AIDS.

about

Medication adherence to antiretroviral therapy among newly treated people living with HIV.

P2860

Q55518641-021AAF0D-5410-4590-BD1D-6059FDD34AF7

P2860

A Novel Integrated Cognitive-Behavioral Therapy for Anxiety and Medication Adherence Among Persons Living With HIV/AIDS.

Item

http://www.wikidata.org/entity/Q54214608

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

A Novel Integrated Cognitive-B ...... Persons Living With HIV/AIDS.

@en

A Novel Integrated Cognitive-B ...... Persons Living With HIV/AIDS.

@nl

type

Item

label

A Novel Integrated Cognitive-B ...... Persons Living With HIV/AIDS.

@en

A Novel Integrated Cognitive-B ...... Persons Living With HIV/AIDS.

@nl

prefLabel

A Novel Integrated Cognitive-B ...... Persons Living With HIV/AIDS.

@en

A Novel Integrated Cognitive-B ...... Persons Living With HIV/AIDS.

@nl

P1476

A Novel Integrated Cognitive-B ...... Persons Living With HIV/AIDS.

@en

P2093

Chad Lemaire

http://www.w3.org/2001/XMLSchema#string

Charles P Brandt

http://www.w3.org/2001/XMLSchema#string

Daniel J Paulus

http://www.w3.org/2001/XMLSchema#string

Monica Garza

http://www.w3.org/2001/XMLSchema#string

Peter J Norton

http://www.w3.org/2001/XMLSchema#string

P2860

Anxiety symptoms and disorders among adults living with HIV and AIDS: A critical review and integrative synthesis of the empirical literature

Development and validation of brief measures of positive and negative affect: the PANAS scales

The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample.

Risk factors and symptoms associated with pain in HIV-infected adults.

Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.

Effect of transdiagnostic cbt for anxiety disorders on comorbid diagnoses.

Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan.

Mental health outcomes during colorectal cancer survivorship: a review of the literature.

Robust dimensions of anxiety sensitivity: development and initial validation of the Anxiety Sensitivity Index-3.

ACT HEALTHY: A Combined Cognitive-Behavioral Depression and Medication Adherence Treatment for HIV-Infected Substance Users.

P304

105-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CBPRA.2017.01.007

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael J. Zvolensky

P577

2017-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29750006

http://www.w3.org/2001/XMLSchema#string

P921

AIDS

P932

5937542

http://www.w3.org/2001/XMLSchema#string

A Novel Integrated Cognitive-Behavioral Therapy for Anxiety and Medication Adherence Among Persons Living With HIV/AIDS.

about

P2860

P2860

A Novel Integrated Cognitive-Behavioral Therapy for Anxiety and Medication Adherence Among Persons Living With HIV/AIDS.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932